Clinical Trials
14 trialsNCT02581137 2026-04-13
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT07078838 2026-01-16
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Not yet recruiting
NCT02333435 2025-11-20
RCT-EPA
CHU de Quebec-Universite Laval
Phase 2 Active not recruiting
NCT03268993 2023-04-07
Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer
University of Pittsburgh
Phase NA Completed
NCT05801887 2023-04-06
ESWT
Krishnadevaraya College of Dental Sciences & Hospital
Phase NA Completed
NCT03182959 2021-06-21
Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer
University of Arizona
Phase EARLY_PHASE1 Completed
NCT01610544 2018-07-05
18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT02167919 2017-09-14
Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)
University of North Carolina, Chapel Hill
Phase NA Completed
NCT01166763 2016-07-18
Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D
University of Kansas Medical Center
Phase NA Completed
NCT00968656 2014-12-09
FISO PET/CT
Washington University School of Medicine
Phase 1 Completed
NCT00510692 2014-08-22
Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA
S.L.A. Pharma AG
Phase 2/3 Completed
NCT00926315 2012-11-01
Gene Expression Profile of Breast Cancer Samples After Vitamin D Supplementation
University of Sao Paulo General Hospital
Phase NA Unknown
NCT00432913 2008-10-17
Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa
S.L.A. Pharma AG
Phase 2/3 Completed
NCT00017927 2008-03-04
A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome
National Institutes of Health Clinical Center (CC)
Phase 3 Completed